- Home
- UPLD vs ICCC Comparison
UPLD vs ICCC Comparison
Compare UPLD & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPLD
- ICCC
- Stock Information
- Founded
- UPLD 2010
- ICCC 1982
- Country
- UPLD United States
- ICCC United States
- Employees
- UPLD N/A
- ICCC N/A
- Industry
- UPLD Computer Software: Prepackaged Software
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- UPLD Technology
- ICCC Health Care
- Exchange
- UPLD Nasdaq
- ICCC Nasdaq
- Market Cap
- UPLD 73.9M
- ICCC 60.1M
- IPO Year
- UPLD 2014
- ICCC 1987
- Fundamental
- Price
- UPLD $2.41
- ICCC $5.65
- Analyst Decision
- UPLD Strong Buy
- ICCC
- Analyst Count
- UPLD 1
- ICCC 0
- Target Price
- UPLD $4.50
- ICCC N/A
- AVG Volume (30 Days)
- UPLD 816.4K
- ICCC 6.8K
- Earning Date
- UPLD 11-06-2025
- ICCC 11-12-2025
- Dividend Yield
- UPLD N/A
- ICCC N/A
- EPS Growth
- UPLD N/A
- ICCC N/A
- EPS
- UPLD N/A
- ICCC 0.20
- Revenue
- UPLD $251,757,000.00
- ICCC $28,274,756.00
- Revenue This Year
- UPLD N/A
- ICCC N/A
- Revenue Next Year
- UPLD N/A
- ICCC N/A
- P/E Ratio
- UPLD N/A
- ICCC $29.40
- Revenue Growth
- UPLD N/A
- ICCC 21.75
- 52 Week Low
- UPLD $1.69
- ICCC $3.34
- 52 Week High
- UPLD $5.64
- ICCC $7.60
- Technical
- Relative Strength Index (RSI)
- UPLD 48.86
- ICCC 36.65
- Support Level
- UPLD $2.29
- ICCC $5.59
- Resistance Level
- UPLD $2.59
- ICCC $6.42
- Average True Range (ATR)
- UPLD 0.20
- ICCC 0.25
- MACD
- UPLD -0.04
- ICCC -0.05
- Stochastic Oscillator
- UPLD 16.22
- ICCC 4.26
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.